Stocks › PHR
Phreesia Inc (PHR) stock analysis
SKIP 2% confidence · analysed Sep 2, 2026
This analysis is from Sep 2, 2026 and may be out of date.
On Sep 2, 2026, our model rated Phreesia Inc (PHR) SKIP with 2% confidence at a price of $12.15. That means the signals cancel out; the model sees no clear edge either way.
Technical picture
The 14-day RSI is 46, close to the neutral 50 line, so momentum is balanced.
MACD is below its signal line, so short-term momentum is pointing down.
The price is above its 50-day moving average but still below the 200-day: a short-term recovery inside a longer-term downtrend.
Volume is only 0.1x its 20-day average; light trading makes the latest move less convincing.
Fundamentals
The company reports a profit margin of 1.9% and revenue growth of +12.9%.
In its latest quarter it earned $0.19 per share, which missed the $0.29 analysts expected, with revenue +12.9% year over year.
Wall Street's average rating is 2.0 on a 1 (strong buy) to 5 (sell) scale, roughly a "buy", with an average price target of $13.94.
The next earnings report is expected around Sep 2, 2026; prices often move sharply around earnings.
Research notes
PHR’s bull case remains that analysts still see a Hold with a $16.65 average target, implying meaningful upside from the current ~$11.84–$11.75 trading range. The bear case is that the stock is still pricing in a lot of execution risk after multiple recent EPS misses versus estimates, even though revenue has generally landed near expectations. The biggest near-term catalyst is the Q2 2027 earnings report scheduled for today, which the market is waiting on, and that event could reset sentiment quickly. Latest public information and price action are consistent with the prior positive view, but only modestly so: the stock is roughly flat-to-down about 1.2% since $11.96, while the setup still shows upside if earnings are solid.
The model's one-paragraph read
No clear edge (SKIP) — composite score +0.02 (SKIP). Technicals: RSI 46.25, MACD bearish, price above SMA50. Fundamentals: margin 1.9%, revenue growth 12.9%. Financial results: YoY revenue +12.9%, last EPS surprise -34.5%, next earnings 2026-09-02. FinGPT news read: neutral. Memory: 3 prior look(s); 25% of directional calls matched later price. Internet research: PHR’s bull case remains that analysts still see a Hold with a $16.65 average target, implying meaningful upside from the current ~$11.84–$11.75 trading range. The bear case is that the stock is still pricing in a lot of execution risk after multiple recent EPS misses versus estimates, even though revenue has generally landed near expectations. The biggest near-term catalyst is the Q2 2027 earnings report scheduled for today, which the market is waiting on, and that event could reset sentiment quickly. Latest public information and price action are consistent with the prior positive view, but only modestly so: the stock is roughly flat-to-down about 1.2% since $11.96, while the setup still shows upside if earnings are solid. Reference price $11.89; no trade levels (SKIP).
Past ratings for PHR
| Date | Verdict | Confidence | Price | Move since | |
|---|---|---|---|---|---|
| Sep 2, 2026 | SKIP | 2% | $12.15 | — | |
| Aug 31, 2026 | SKIP | 6% | $12.12 | +0.2% | |
| Aug 28, 2026 | SKIP | 0% | $12.22 | -0.6% | |
| Aug 27, 2026 | WEAK BUY | 23% | $12.02 | +1.1% | ✔ right direction |
| Aug 21, 2026 | SKIP | 11% | $12.03 | +1.0% | |
| Aug 19, 2026 | SKIP | 10% | $11.88 | +2.3% |
"Move since" compares each call's price with the latest analysed price.
Other Healthcare stocks we cover
PRGO · SDZNY · SNN · STE · TCMD · TKNO · UNH · ZBH · ALC · AMGN · AMRX · ANIP
Frequently asked questions
Is PHR a buy right now?
As of Sep 2, 2026, our automated model rates Phreesia Inc (PHR) SKIP with 2% confidence: the signals cancel out; the model sees no clear edge either way. This is a model output for education, not personal investment advice.
When does Phreesia Inc report earnings next?
The next earnings report is expected around Sep 2, 2026.
What does a SKIP rating mean?
A SKIP rating means the signals cancel out; the model sees no clear edge either way.
For information and education only. Not investment advice. Ratings are produced by an automated model, can be wrong, and may be out of date. Do your own research; you can lose money investing. The site's author may hold positions in stocks discussed here.